Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Nov-24 6:23 PM View:  | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 14-Nov-24 | Sale (Planned) | 10,000 | $0.70 | $7,000.00 | (8%) 131.63K to 121.63K | |
| 27-Sep-24 7:38 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 26-Sep-24 | Sale (Planned) | 10,000 | $0.81 | $8,100.00 | (7%) 141.63K to 131.63K | |
| 17-Sep-24 6:14 PM View: | Tom Penny Principal Accounting Officer | Equillium, Inc. (EQ) | 16-Sep-24 | Sale (Planned) | 38,806 | $0.85 | $32,985.10 | (79%) 48.86K to 10.05K | |
| 18-Jul-24 5:52 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 16-Jul-24 | Sale (Planned) | 10,000 | $0.87 | $8,700.00 | (7%) 151.63K to 141.63K | |
| 03-Jan-24 6:10 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 08-Dec-23 | Grant | 8,805 | $0.58 | $5,106.90 | 7% 127.83K to 136.63K | |
| 03-Jan-24 6:12 PM View: | Zedelmayer Christine Sr. Vice President and COO | Equillium, Inc. (EQ) | 08-Dec-23 | Grant | 8,804 | $0.58 | $5,106.32 | 7% 126.44K to 135.25K | |
| 03-Jan-24 6:14 PM View: | Rothman Joel Chief Development Officer | Equillium, Inc. (EQ) | 08-Dec-23 | Grant | 8,804 | $0.58 | $5,106.32 | 18% 49.35K to 58.15K | |
| 03-Jan-24 6:10 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 09-Jun-23 | Grant | 15,000 | $0.56 | $8,400.00 | 13% 112.83K to 127.83K | |
| 03-Jan-24 6:12 PM View: | Zedelmayer Christine Sr. Vice President and COO | Equillium, Inc. (EQ) | 09-Jun-23 | Grant | 15,000 | $0.56 | $8,400.00 | 13% 111.44K to 126.44K | |
| 03-Jan-24 6:14 PM View: | Rothman Joel Chief Development Officer | Equillium, Inc. (EQ) | 09-Jun-23 | Grant | 15,000 | $0.56 | $8,400.00 | 44% 34.35K to 49.35K | |
| 04-Jan-23 6:48 PM View: | Rothman Joel Chief Development Officer | Equillium, Inc. (EQ) | 09-Dec-22 | Grant | 3,821 | $1.19 | $4,546.99 | 13% 30.52K to 34.35K | |
| 04-Jan-23 6:50 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 09-Dec-22 | Grant | 4,444 | $1.19 | $5,288.36 | 4% 108.38K to 112.83K | |
| 30-Aug-22 5:57 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 29-Aug-22 | Sale (Planned) | 7,000 | $2.83 | $19,810.00 | (6%) 115.38K to 108.38K | |
| 04-Jan-23 6:48 PM View: | Rothman Joel Chief Development Officer | Equillium, Inc. (EQ) | 10-Jun-22 | Grant | 6,244 | $1.85 | $11,551.40 | 26% 24.28K to 30.52K | |
| 04-Jan-23 6:43 PM View: | Zedelmayer Christine Sr. Vice President and COO | Equillium, Inc. (EQ) | 10-Jun-22 | Grant | 9,033 | $1.85 | $16,711.10 | 9% 102.41K to 111.44K | |
| 06-Jun-22 9:17 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 06-Jun-22 | Sale (Planned) | 5,000 | $2.52 | $12,600.00 | (4%) 113.02K to 108.02K | |
| 05-Apr-22 5:40 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 04-Apr-22 | Market Sale (Planned) | 8,000 | $3.18 | $25,440.00 | (7%) 121.02K to 113.02K | (9%) |
| 13-Dec-21 9:58 AM View: | Rothman Joel Chief Development Officer | Equillium, Inc. (EQ) | 10-Dec-21 | Grant | 1,290 | $2.35 | $3,031.50 | 6% 22.99K to 24.28K | |
| 13-Dec-21 10:01 AM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 10-Dec-21 | Grant | 5,585 | $2.35 | $13,124.70 | 5% 115.43K to 121.02K | |
| 03-Dec-21 1:57 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 01-Dec-21 | Market Sale (Planned) | 5,000 | $5.08 | $25,401.50 | (4%) 120.43K to 115.43K | 7% |
| 17-Nov-21 3:27 PM View: | Zedelmayer Christine Sr. Vice President and COO | Equillium, Inc. (EQ) | 16-Nov-21 | Option Exercise | 23,334 | $2.45 | $57,168.30 | 26% 90.51K to 113.84K | |
| 17-Nov-21 3:27 PM View: | Zedelmayer Christine Sr. Vice President and COO | Equillium, Inc. (EQ) | 16-Nov-21 | Market Option Sale (Planned) | 11,434 | $5.49 | $62,715.50 | (10%) 113.84K to 102.41K | |
| 07-Oct-21 9:02 PM View: | Connelly Stephen Chief Scientific Officer Director | Equillium, Inc. (EQ) | 06-Oct-21 | Market Option Sale (Planned) | 8,092 | $7.01 | $56,706.10 | (< 1%) 1.0M to 993.0K | |
| 07-Oct-21 9:02 PM View: | Connelly Stephen Chief Scientific Officer Director | Equillium, Inc. (EQ) | 06-Oct-21 | Option Exercise | 8,092 | $4.16 | $33,626.40 | < 1% 993.0K to 1.0M | |
| 29-Sep-21 1:02 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 27-Sep-21 | Market Sale (Planned) | 8,000 | $6.74 | $53,924.00 | (6%) 128.43K to 120.43K | 1% |
| 28-Jul-21 11:55 AM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 27-Jul-21 | Market Sale (Planned) | 5,000 | $5.72 | $28,585.00 | (4%) 133.43K to 128.43K | (2%) |
| 14-Jun-21 5:55 PM View: | Rothman Joel Chief Development Officer | Equillium, Inc. (EQ) | 10-Jun-21 | Grant | 7,742 | $2.35 | $18,193.70 | 51% 15.25K to 22.99K | |
| 14-Jun-21 5:56 PM View: | Zedelmayer Christine Sr. Vice President and COO | Equillium, Inc. (EQ) | 10-Jun-21 | Grant | 9,032 | $2.35 | $21,225.20 | 11% 81.48K to 90.51K | |
| 14-Jun-21 5:56 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 10-Jun-21 | Grant | 5,535 | $2.35 | $13,007.20 | 45% 12.18K to 17.71K | |
| 09-Jun-21 6:03 AM View: | Connelly Stephen Chief Scientific Officer Director | Equillium, Inc. (EQ) | 08-Jun-21 | Option Exercise | 10,495 | $4.75 | $49,851.20 | 1% 993.0K to 1.0M | |
| 09-Jun-21 6:03 AM View: | Connelly Stephen Chief Scientific Officer Director | Equillium, Inc. (EQ) | 08-Jun-21 | Market Option Sale | 10,495 | $7.18 | $75,315.30 | (1%) 1.0M to 993.0K | |
| 09-Jun-21 6:03 AM View: | Connelly Stephen Chief Scientific Officer Director | Equillium, Inc. (EQ) | 07-Jun-21 | Market Option Sale | 22,390 | $7.12 | $159,409.00 | (2%) 1.02M to 993.0K | |
| 09-Jun-21 6:03 AM View: | Connelly Stephen Chief Scientific Officer Director | Equillium, Inc. (EQ) | 07-Jun-21 | Option Exercise | 22,390 | $4.01 | $89,797.00 | 2% 993.0K to 1.02M | |
| 09-Jun-21 6:03 AM View: | Connelly Stephen Chief Scientific Officer Director | Equillium, Inc. (EQ) | 04-Jun-21 | Option Exercise | 13,539 | $3.81 | $51,617.70 | 1% 993.0K to 1.01M | |
| 09-Jun-21 6:03 AM View: | Connelly Stephen Chief Scientific Officer Director | Equillium, Inc. (EQ) | 04-Jun-21 | Market Option Sale | 13,539 | $7.01 | $94,845.90 | (1%) 1.01M to 993.0K | |
| 28-May-21 6:20 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 26-May-21 | Market Sale (Planned) | 5,000 | $6.50 | $32,483.50 | (4%) 120.72K to 115.72K | (4%) |
| 30-Dec-20 5:00 PM View: | Connelly Stephen Chief Scientific Officer Director | Equillium, Inc. (EQ) | 28-Dec-20 | Market Sale (Planned) | 25,000 | $4.52 | $113,045.00 | (2%) 1.02M to 993.0K | (37%) |
| 28-Dec-20 9:15 AM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 23-Dec-20 | Market Sale (Planned) | 8,000 | $4.74 | $37,913.60 | (6%) 140.9K to 132.9K | 2% |
| 11-Dec-20 5:00 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 10-Dec-20 | Acquisition (other) | 5,362 | $2.35 | $12,600.70 | 4% 135.53K to 140.9K | |
| 11-Dec-20 5:00 PM View: | Zedelmayer Christine Sr. Vice President and COO | Equillium, Inc. (EQ) | 10-Dec-20 | Acquisition (other) | 1,097 | $2.35 | $2,577.95 | 1% 80.38K to 81.48K | |
| 30-Sep-20 5:00 PM View: | Connelly Stephen Chief Scientific Officer Director | Equillium, Inc. (EQ) | 28-Sep-20 | Market Sale (Planned) | 25,000 | $5.62 | $140,395.00 | (2%) 1.04M to 1.02M | 16% |
| 15-Jul-20 5:00 PM View: | Connelly Stephen Chief Scientific Officer Director | Equillium, Inc. (EQ) | 13-Jul-20 | Market Sale (Planned) | 250,000 | $8.13 | $2,033,470.00 | (19%) 1.29M to 1.04M | 42% |
| 12-Jun-20 4:30 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 10-Jun-20 | Acquisition (other) | 5,014 | $2.41 | $12,083.70 | 4% 130.52K to 135.53K | |
| 12-Jun-20 4:30 PM View: | Zedelmayer Christine Sr. Vice President and COO | Equillium, Inc. (EQ) | 10-Jun-20 | Acquisition (other) | 9,570 | $2.41 | $23,063.70 | 14% 70.81K to 80.38K | |
| 19-Feb-20 5:48 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 18-Feb-20 | Market Sale (Planned) | 5,000 | $5.03 | $25,137.50 | (4%) 135.52K to 130.52K | 6% |
| 22-Jan-20 8:13 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 21-Jan-20 | Market Sale (Planned) | 5,000 | $4.41 | $22,043.00 | (4%) 140.52K to 135.52K | (7%) |
| 04-Sep-19 5:35 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 03-Sep-19 | Market Sale (Planned) | 5,000 | $3.60 | $17,980.50 | (3%) 143.72K to 138.72K | (30%) |
| 05-Aug-19 5:04 PM View: | Keyes Jason A Chief Financial Officer | Equillium, Inc. (EQ) | 01-Aug-19 | Market Sale (Planned) | 5,000 | $3.99 | $19,941.00 | (3%) 148.72K to 143.72K | (18%) |
| 16-Oct-18 5:51 PM View: | Steel Bruce D. President, CBO Director | Equillium, Inc. (EQ) | 16-Oct-18 | Acquisition (other) | 48,495 | $11.20 | $543,144.00 | 1% 3.66M to 3.71M | |
| 16-Oct-18 5:39 PM View: | Bradbury Daniel Chief Executive Officer Director | Equillium, Inc. (EQ) | 16-Oct-18 | Acquisition (other) Duplicate | 48,495 | $11.20 | $543,144.00 | 1% 3.66M to 3.71M |
